...
首页> 外文期刊>Clinical and Translational Medicine >Retracted: CD248 as a novel therapeutic target in pulmonary arterial hypertension
【24h】

Retracted: CD248 as a novel therapeutic target in pulmonary arterial hypertension

机译:<斜视切换=“是”>缩回:CD248作为肺动脉高压的新型治疗靶标

获取原文
           

摘要

The following article from Clinical and Translational Medicine, “CD248 as a novel therapeutic target in pul- monary arterial hypertension” by Tao Xu, Lei Shao, Aimei Wang, Rui Liang, Yuhan Lin, GuanWang, Yan Zhao, Jing Hu, and Shuangyue Liu, 1 published online on Septem- ber 17, 2020 in Wiley Online Library (wileyonlinelibrary. com), has been retracted by agreement between the authors,thejournalEditor-in-Chief,XiangdongWangand JohnWiley&Sons,Ltd.Theretractionhasbeenagreeddue to duplicate use of figures and data in the article.
机译:以下文章从临床和翻译医学中,“CD248作为肺部动脉高血压的新疗法靶标”由陶旭,雷邵,安梅王,瑞良,玉汉林,关旺,严赵,景胡,和双岳刘 ,1在线在线发布于2020年在Wiley在线图书馆(WileyonlineLibrary。COM),由作者,journaleditor-in-in,xiangdongwangand johnwiley&amp之间的协议撤回了;儿子,Ltd.tratchhasbeenagreeddue,重复使用数字和数据 文章中的数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号